Services Based on Organoid Technology via Cellsion Technologies
1 March 2024
Cellsion Technologies offer all kinds of services related to Biotechnology and stands to be one of the standard service provider. The research team always welcome queries relating to potential
evaluation of experiments to fulfill their customers. We wholeheartedly encourage the association with life sciences companies, universities, academic institutions, eminent scientists and other
members.
Our services is based on organoid technology and includes disease model development and biobanking for a range of disease, drug screening and clinical trials in a dish (CTiD) platform for preclinical patient stratification and personalized medicine approaches.
Disease Model evelopment
We can support your drug testing needs for a variety of disease areas where clinically relevant disease models are yet to be developed.